Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1172 | Obesity | ICEECE2012

Ac 2-26, an annexin A1-derived peptide, reduces inflammation in human SGBS adipocytes after hypoxia treatment

Kosicka-Knox A. , Cunliffe A. , Mackenzie R. , Zariwala M. , Renshaw D.

Previous studies demonstrated that the N-terminal peptide of annexin A1 (AnxA1) (peptide Ac2-26) can mimic the anti-inflammatory actions of the full-length protein in various systems. In the current study, we report the effectiveness of the peptide Ac2-26 as an anti-inflammatory agent in a model of human SGBS adipocytes. We have previously demonstrated that plasma AnxA1 protein is significantly inversely correlated with BMI, body fat level and waist to hip ratio. We have also ...

ea0029p1467 | Pituitary Clinical | ICEECE2012

Predictors of the acromegaly-associated mortality in the last decade

Galoiu S , Ioacara S , Baciu I , Coculescu M

Introduction: Acromegaly is associated with an increased mortality in untreated patients. Recent papers suggest an improvement of survival in the last years.Aims: To assess mortality ratio and to identify prognostic factors associated with mortality in acromegaly in the last decade.Methods: 297 patients (186 F/111 M, mean age 49.8±0.7 years) with acromegaly admitted in a single Neuroendocrinology Department between Jan 2001 an...

ea0029p1526 | Pituitary Clinical | ICEECE2012

Growth hormone effects on lipid profile in patients with acromegaly

Mykytuyk M. , Khyzhnyak O. , Sulima T. , Karachentsev Y.

Introduction: Active acromegaly is associated with increased mortality, which has been attributed largely to cardiovascular disease.Aims: To evaluate the effects of chronic excess of GH and IGF1 on lipid metabolism in patients with active acromegaly.Subjects and methods: Ninety-seven patients (37 men and 60 women; aged 18–76 years) with macroadenoma of hypophysis (67 – somatotropinoma, 30 – somatomammotropinoma) were...

ea0011p634 | Neuroendocrinology and behaviour | ECE2006

Glucose-suppressed GH levels compared with IGF-I levels in patients with acromegaly

Steffin B , Gutt B , Roemmler J , Bidlingmaier M , Schopohl J

Nadir growth hormone (GH) levels after oral glucose tolerance test (OGTT) as well as random insulin-like growth-factor I (IGF-I) levels, given as multiples of the upper limit of normal [xULN], were used to evaluate biochemical activitiy of acromegalic patients. The development of new, more sensitive GH assays makes it necessary to reevaluate the cut off values of the GH nadir after OGTT.In a cross sectional study, we evaluated nadir GH concentrations dur...

ea0089b11 | Basic Science | NANETS2022

Patient-Derived Organoids and Their Potential for Precision Medicine in Neuroendocrine Tumors

N Cortez Briana , Kumar Suresh , Arakawa Yasuhiro , Varghese Diana , Kaplan Rosandra , Reilly Karlyne , Widemann Brigitte , Hernandez Jonathan M. , Thomas Craig , Pommier Yves , Roper Nitin , Del Rivero Jaydira

Background: Neuroendocrine tumors (NETs) are a heterogeneous group of malignant neoplasms arising from neuroendocrine cells distributed throughout the body. The most common sites of NETs are the gastrointestinal tract, pancreas and lungs. The clinical management of NETs is not standardized, with few FDA-approved therapies. Moreover, drug development has been challenging for NETs due to limited pre-clinical models. To address this unmet need, the NCI Natural History Study of Ch...

ea0041gp26 | Adrenal (2) | ECE2016

LCI699 is a potent inhibitor of cortisol production in vitro

Creemers Sara G , Feelders Richard A , de Jong Frank H , Franssen Gaston J H , de Rijke Yolanda B , van Koetsveld Peter M , Hofland Leo J

Introduction: The steroidogenesis inhibitors ketoconazole and metyrapone are frequently used for treatment of Cushing’s syndrome, but can cause side effects. LCI699 is a known 11β-hydroxylase inhibitor, but effects on other steroidogenic enzymes are unknown. We aimed to compare effects of LCI699, ketoconazole, and metyrapone in vitro.Methods: HAC-15 cells, with or without 10 nM ACTH, and three primary human adrenocortical adenoma cultu...

ea0037ep94 | Adrenal cortex | ECE2015

Combined effects of sirolimus and mitotane in the inhibition of growth in human adrenocortical carcinoma cells

De Martino Maria Cristina , van Koetsveld Peter M , Feeldes Richard A , Lamberts Steven W J , de Herder Wouter W , Colao Annamaria , Pivonello Rosario , Hofland Leo J

Adrenocortical cancer (ACC) is a rare cancer with poor prognosis and scant treatment options. Mitotane alone, or in combination with cytotoxic chemotherapy, represents the referral current treatment for patients with unresectable ACC. Recent studies have shown that mTOR inhibitors suppress growth of ACC cells. This study aimed at evaluating the effects of mitotane in combination with mTOR inhibitors. In H295 and SW13 cells we tested the effects of a 6 day treatment with increa...

ea0065op5.1 | Reproductive Endocrinology and Biology | SFEBES2019

Hypothalamic-pituitary-gonadal (HPG) axis suppression during basic military training in women despite increased adiposity and insulin resistance

Gifford Robert M , O'Leary Thomas J , Wardle Sophie L , Greeves Julie P , Anderson Richard A , Woods David R , Reynolds Rebecca M

Background: Low energy availability (LEA) in female athletes can result in HPG axis suppression. Basic military training (BMT) is physically arduous and associated with amenorrhoea and low-trauma fractures. We hypothesised that women undergoing BMT would demonstrate evidence of LEA and suppressed HPG function.Design: Prospective study of 61 women undertaking 11-month BMT. Subjects acted as their own controls at baseline (all measures). Body composition m...

ea0029p341.1 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Cardiac hormones are dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor

Nguyen J P , Frost C D , Lane M L , Skelton W P , Skelton M , Vesely D L

Introduction: The growth of human tumors depends on the formation of new blood vessels and vascular endothelial growth factor (VEGF) helps control this process via inducing new capillaries to sprout from pre-existing blood vessels. Four cardiac hormones which eliminate up to 80% of human pancreatic cancers and up to 86% of human small-cell lung cancers growing in mice were investigated for their effects on VEGF and the VEGFR2/KDR/Flk-1 receptor. The VEGFR2 receptor is the main...

ea0029p1420 | Pituitary Clinical | ICEECE2012

Symptomatic hypotonic hyponatraemia after endoscopic transsphenoidal surgery: results from two large series

Faustini-Fustini M. , Zoli M. , Mazzatenta D. , Frank G. , Kunicki J. , Sherry I. , Garni B. , Laws E.

Introduction: The incidence of hyponatremia as a delayed complication of transsphenoidal surgery varies widely from study to study and much of the debate has focused on the symptomatic hypotonic hyponatremia (SHH) occurring usually after discharge.Aim/Design: We studied the incidence, risk factors, course and management of postoperative SHH in two large series of endoscopic transsphenoidal surgery (ETS) for pituitary tumors.Results...